JPRN-UMIN000019975已完成4 期
The efficacy of dulaglutide in diabetic patients - The efficacy of dulaglutide in diabetic patients
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients having infectious diseases, thyroid disease, or malignant tumors. Patients being treated with steroids.
研究者
相似试验
已完成
不适用
The efficacy of Dulaglutide in patients with diabetes undergoing hemodialysis.Patients with diabetes undergoing hemodialysis.JPRN-UMIN000039525agasaki Kidney Hospital Department of nephrology18
招募中
不适用
Efficacy and safety of dulaglutide in the treatment of type 2 diabetesType 2 diabetes mellitus patientsJPRN-UMIN000027255Department of nephrology, Matsunami general hospital30
招募中
2 期
The effect and safety of dulaglutide for hyperglycemia associated with R-CHOP thepapyMalignant lymphomaJPRN-jRCT1031200022Suyama Takuya10
进行中（未招募）
1 期
Personalized treatment of type 2 diabetesEUCTR2020-000913-33-SEniversity of gothenburg200
进行中（未招募）
不适用
iraglutide Effect and Action in Diabetes (LEAD-2): Effect on glycaemic control after once daily administration of liraglutide in combination with metformin versus metformin monotherapy versus metformin and glimepiride combination therapy in subjects with type 2 diabetes. A six-month double-blind, double-dummy, randomised, active control, parallel-group, multi-centre, multi-national trial with an 18 months trial extension periodMedDRA version: 8,0Level: PTClassification code 10012601Diabetes MellitusEUCTR2005-003417-32-BEovo Nordisk A/S1,865